1 Volmink J, Garner P. Directly observed therapy for treating tuberculosis. Cochrane Database Syst Rev 2007; Oct 17 (4): CD003343. 2 Decroo T, Telfer T, Biot M, et al. Distribution of antiretroviral treatment through self-forming groups of patients in Tete Province, Mozambique. J Acquir Immune Defic Syndr 2011; 56: e39–e44. 3 Luque-Fernández M, Van Cutsem G, Goemaere E, et al. Patient adherence clubs: a new model of care to reinforce long-term retention on antiretroviral therapy in Khayelitsha, Cape Town. Seattle, WA, USA: 19th Conference on Retroviruses and Opportunistic Infections, 2012 [Poster 1150, Z-128]. http://www. retro conference. org/2012b/Sessions/202. htm Accessed August 2012. 4 Kielmann K, Cataldo F. Tracking the rise of the expert patient in evolving paradigms of HIV care. AIDS Care 2010; 22: 21–28. 5 Jaffar S, Amuron B, Foster S, et al. Rates of virological failure in patients treated in a home-based versus a facility-based HIV-care model in Jinja, Southeast Uganda: a cluster-randomised equivalence trial. Lancet 2009; 374: 2080–2089. 6 Selke HM, Kimaiyo S, Sidle JE, et al. Task-shifting of antiretroviral delivery from health care workers to persons living with HIV/AIDS: clinical outcomes of a community-based program in Kenya. J Acquir Immune Defic Syndr 2010; 55: 483–490. 7 World Health Organization. WHO policy on collaborative TB/HIV activities: guidelines for national programmes and other stakeholders. WHO/HTM/TB/2012.1, WHO/HIV/2012.1. Geneva, Switzerland: WHO, 2012. 8 South Africa Department of Health. A practical guide for TB and HIV service integration at primary health care facilities. Pretoria, South Africa: Department of Health, 2010.